Aurobindo Pharma Limited (AUROPHARMA)
NSEINR 1132.5-0.2%
Price Chart
Key Statistics
Market Cap
INR 659.09B
P/E Ratio
18.94
Revenue (TTM)
INR 317.24B
Volume
961.88K
52W High
INR 1592.00
52W Low
INR 1010.00
Dividend Yield
0.00%
Beta
0.22
Technicals
50-Day MA
1172.552
200-Day MA
1228.1288
52 Week High
1592
52 Week Low
1010
About AUROPHARMA
Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto R.
Employees
N/A
Headquarters
Hyderabad, India
CEO
Mr. Kambam Nithyananda Reddy
Latest News
AUROPHARMA Outlook for the Week (June 30, 2025 – July 04, 2025) - Equitypandit
4 days ago • Google News
Earnings To Watch: Aurobindo Pharma Ltd (NSE:AUROPHARMA) Reports Q4 2025 Result - GuruFocus
2025-05-26 • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
38.43
Percentile: 81.1
Environmental Risk Score
3.81
Percentile: 2
Social Risk Score
21.42
Percentile: 2
Governance Risk Score
16.2
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
AUROPHARMA
Category Average
3Significant Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg